BioCentury | May 25, 2017
Finance

Europe’s translational springtime

...Product targeting cAMP-degrading phosphodiesterase enzymes Renal; Inflammation; Cancer Preclinical Enterprise Therapeutics Ltd. 2014 Falmer, U.K. University of Sussex...
BioCentury | Oct 20, 2016
Finance

3Q16 Public-Private Partnership Roundup

...European Bank for induced Pluripotent Stem Cells Consortium and is working on a project with University of Sussex...
...Headington, U.K. University of California Los Angeles, Los Angeles, Calif. University of Minnesota, Minneapolis, Minn. University of Sussex...
...Therapeutics Inc. Kite Pharma Inc. Memorial Sloan Kettering Cancer Center Structural Genomics Consortium University of California Los Angeles University of Minnesota University of Sussex Wellcome...
BioCentury | Mar 10, 2011
Distillery Therapeutics

Indication: Cancer

...M.M.U. et al. EMBO J.; published online Feb. 11, 2011; doi:10.1038/emboj.2011.18 Contact: Laurence H. Pearl, University of Sussex...
BioCentury | Mar 10, 2011
Cover Story

Cancer stress tests

...Genome Damage and Stability Centre and head of the School of Life Sciences at the University of Sussex...
...Palo Alto, Calif. Stanford University , Stanford, Calif. University of Cambridge , Cambridge, U.K. University of Sussex...
...al. EMBO J. ; published online Feb. 11, 2011; doi: 10.1038/emboj.2011.18 Contact: Laurence H. Pearl, University of Sussex...
BioCentury | Oct 13, 1997
Emerging Company Profile

Cerebrus Ltd.

...University collaborators: Nine, including University of California at San Francisco, University of Dundee and the University of Sussex...
BioCentury | Jun 30, 1997
Politics, Policy & Law

Keygene: he best of times . . . the worst of times?

...of the report's major contributors, Julian Burke of the School of Biological Sciences at the University of Sussex...
BioCentury | Apr 8, 1996
Company News

University of Sussex other research news

...Next is immune system-related patents, such as interleukins and their receptors. The authors, from the University of Sussex...
...on what could be done to tip the balance toward patent filings by European companies. University of Sussex...
Items per page:
1 - 7 of 7
BioCentury | May 25, 2017
Finance

Europe’s translational springtime

...Product targeting cAMP-degrading phosphodiesterase enzymes Renal; Inflammation; Cancer Preclinical Enterprise Therapeutics Ltd. 2014 Falmer, U.K. University of Sussex...
BioCentury | Oct 20, 2016
Finance

3Q16 Public-Private Partnership Roundup

...European Bank for induced Pluripotent Stem Cells Consortium and is working on a project with University of Sussex...
...Headington, U.K. University of California Los Angeles, Los Angeles, Calif. University of Minnesota, Minneapolis, Minn. University of Sussex...
...Therapeutics Inc. Kite Pharma Inc. Memorial Sloan Kettering Cancer Center Structural Genomics Consortium University of California Los Angeles University of Minnesota University of Sussex Wellcome...
BioCentury | Mar 10, 2011
Distillery Therapeutics

Indication: Cancer

...M.M.U. et al. EMBO J.; published online Feb. 11, 2011; doi:10.1038/emboj.2011.18 Contact: Laurence H. Pearl, University of Sussex...
BioCentury | Mar 10, 2011
Cover Story

Cancer stress tests

...Genome Damage and Stability Centre and head of the School of Life Sciences at the University of Sussex...
...Palo Alto, Calif. Stanford University , Stanford, Calif. University of Cambridge , Cambridge, U.K. University of Sussex...
...al. EMBO J. ; published online Feb. 11, 2011; doi: 10.1038/emboj.2011.18 Contact: Laurence H. Pearl, University of Sussex...
BioCentury | Oct 13, 1997
Emerging Company Profile

Cerebrus Ltd.

...University collaborators: Nine, including University of California at San Francisco, University of Dundee and the University of Sussex...
BioCentury | Jun 30, 1997
Politics, Policy & Law

Keygene: he best of times . . . the worst of times?

...of the report's major contributors, Julian Burke of the School of Biological Sciences at the University of Sussex...
BioCentury | Apr 8, 1996
Company News

University of Sussex other research news

...Next is immune system-related patents, such as interleukins and their receptors. The authors, from the University of Sussex...
...on what could be done to tip the balance toward patent filings by European companies. University of Sussex...
Items per page:
1 - 7 of 7